Regulatory T Cell Modulation of the Alveolar Epithelium in Acute Lung Injury

急性肺损伤中肺泡上皮的调节性 T 细胞调节

基本信息

  • 批准号:
    8396464
  • 负责人:
  • 金额:
    $ 5.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-20 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The global objective of this NRSA Individual Fellowship Application is to facilitate development of essential skills that will allow the candidae to become an academic physician-scientist. The candidate and his mentor have designed a training plan that will include a rigorous research component along with didactic instruction to establish the thought processes and principles necessary for successful career development. Acute lung Injury (ALI) and the more severe Acute Respiratory Distress Syndrome (ARDS) are diffuse lung diseases characterized by hypoxemia, capillary leakage, edema, and epithelial cell damage. These processes cause tremendous morbidity and mortality in the United States each year. Despite decades of research into the pathogenesis underlying the development of ALI, mortality remains high. There is a paucity of information known about the resolution phase of ALI; however, Regulatory T cells (Tregs) have been demonstrated to be important in ALI resolution in a mouse endotoxin (LPS) administration model of ALI. Furthermore, Tregs have been detected to increase in bronchoalveolar fluid of patients with ARDS, suggesting that they may be important in the human immunological response to ALI. In acute or chronic injury the failure to regenerate the lung epithelium plays a role in such processes as acute lung injury, pneumonia, pulmonary fibrosis, cancer, COPD, and aging. Recently there has been considerable interest in investigating the cells types involved in repair along with the determinants which regulate these processes. The candidate has preliminary data demonstrating that the presence or absence of Tregs modulates alveolar epithelial repair. This novel finding of Treg modulation of the alveolar epithelium has not been previously described. The focus of this proposal is to further examine Treg effects on the alveolar epithelium during ALI resolution with the hope of identifying novel mechanisms that may lead to potential treatment options in patients with ALI. The specific aims proposed will utilize both in vivo and in vitro techniques to study Treg-alveolar epithelium interactions. In Specific Aim 1, examination of the effect of Tregs on the alveolar epithelial barrier during ALI resolution will be performed alon with evaluation of the alveolar epithelium using multi-color flow cytometry and immunohistochemistry to quantify in vivo epithelial changes. In Specific Aim 2, the impact Tregs exert on alveolar epithelial properties of phenotype and function will be determined through in vitro co-cultures of type II alveolar epithelial cells and Tregs. These experiments will explore new observations concerning Treg modulation of the alveolar epithelium during ALI with the ultimate goal of improving patient outcomes in this oftentimes fatal disease. PUBLIC HEALTH RELEVANCE: Acute lung injury (ALI) is a common pulmonary disease with high morbidity and mortality. Regulatory T Cells (Tregs) have been shown to be important in the resolution of ALI but their potential interaction and modulation of the alveolar epithelium in damage and repair is unknown. We propose to study Treg modulation of alveolar epithelial cells with the hope of identifying novel mechanisms that may ultimately lead to new therapeutic options for this disease.
描述(由申请人提供):此 NRSA 个人奖学金申请的全球目标是促进基本技能的发展,使念珠菌成为学术医师科学家。候选人和他的导师设计了一个培训计划,其中包括严格的研究部分和教学指导,以建立成功职业发展所需的思维过程和原则。急性肺损伤 (ALI) 和更严重的急性呼吸窘迫综合征 (ARDS) 是弥漫性肺部疾病,其特征是低氧血症、毛细血管渗漏、水肿和上皮细胞损伤。这些过程每年在美国造成巨大的发病率和死亡率。尽管对 ALI 发病机制进行了数十年的研究,但死亡率仍然很高。关于 ALI 缓解阶段的已知信息很少;然而,在 ALI 的小鼠内毒素 (LPS) 给药模型中,调节性 T 细胞 (Treg) 已被证明对解决 ALI 具有重要作用。此外,已检测到 ARDS 患者的支气管肺泡液中 Tregs 数量增加,表明它们可能在人类对 ALI 的免疫反应中发挥重要作用。在急性或慢性损伤中,肺上皮再生失败在急性肺损伤、肺炎、肺纤维化、癌症、慢性阻塞性肺病和衰老等过程中发挥着重要作用。最近,人们对研究参与修复的细胞类型以及调节这些过程的决定因素产生了很大的兴趣。候选人有初步数据证明 Tregs 的存在或不存在可调节肺泡上皮修复。 Treg 调节肺泡上皮的这一新发现以前从未被描述过。该提案的重点是进一步检查 ALI 消退过程中 Treg 对肺泡上皮的影响,希望找出可能为 ALI 患者带来潜在治疗选择的新机制。提出的具体目标将利用体内和体内 研究 Treg 与肺泡上皮相互作用的体外技术。在具体目标 1 中,将检查 ALI 消退过程中 Tregs 对肺泡上皮屏障的影响,同时使用多色流式细胞术和免疫组织化学评估肺泡上皮,以量化体内上皮变化。在具体目标 2 中,Tregs 对肺泡上皮表型和功能特性的影响将通过 II 型肺泡上皮细胞和 Tregs 的体外共培养来确定。这些实验将探索有关 ALI 期间 Treg 调节肺泡上皮的新观察结果,最终目标是改善这种常常致命的疾病的患者预后。 公共卫生相关性:急性肺损伤(ALI)是一种常见的肺部疾病,发病率和死亡率很高。调节性 T 细胞 (Treg) 已被证明在 ALI 的解决中很重要,但它们在损伤和修复中对肺泡上皮的潜在相互作用和调节尚不清楚。我们建议研究肺泡上皮细胞的 Treg 调节,希望找到新的机制,最终为这种疾病带来新的治疗选择。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason Robert Mock其他文献

Jason Robert Mock的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason Robert Mock', 18)}}的其他基金

Defining the Role of Regulatory T Cells in Resolution of Acute Lung Injury
定义调节性 T 细胞在解决急性肺损伤中的作用
  • 批准号:
    10316245
  • 财政年份:
    2020
  • 资助金额:
    $ 5.1万
  • 项目类别:
Defining the Role of Regulatory T Cells in Resolution of Acute Lung Injury
定义调节性 T 细胞在解决急性肺损伤中的作用
  • 批准号:
    10532739
  • 财政年份:
    2020
  • 资助金额:
    $ 5.1万
  • 项目类别:
Regulatory T Cells Promote Alveolar Epithelial Repair
调节性 T 细胞促进肺泡上皮修复
  • 批准号:
    9762962
  • 财政年份:
    2016
  • 资助金额:
    $ 5.1万
  • 项目类别:
Regulatory T Cells Promote Alveolar Epithelial Repair
调节性 T 细胞促进肺泡上皮修复
  • 批准号:
    9180313
  • 财政年份:
    2016
  • 资助金额:
    $ 5.1万
  • 项目类别:

相似国自然基金

ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
  • 批准号:
    82372185
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
土家药山姜通过调控中性粒细胞胞外捕获网的急性肺损伤保护作用及机制研究
  • 批准号:
    82360846
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
  • 批准号:
    32360897
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
  • 批准号:
    82360024
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 5.1万
  • 项目类别:
Midlife cardiovascular stress physiology and preclinical cerebrovascular disease
中年心血管应激生理学与临床前脑血管疾病
  • 批准号:
    10720054
  • 财政年份:
    2023
  • 资助金额:
    $ 5.1万
  • 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
  • 批准号:
    10727092
  • 财政年份:
    2023
  • 资助金额:
    $ 5.1万
  • 项目类别:
Predicting ECMO NeuroLogICal Injuries using mAchiNe Learning (PELICAN)
使用机器学习预测 ECMO 神经损伤 (PELICAN)
  • 批准号:
    10719312
  • 财政年份:
    2023
  • 资助金额:
    $ 5.1万
  • 项目类别:
Development of a Neutrophil Degranulation Inhibitor to Treat ARDS
开发治疗 ARDS 的中性粒细胞脱颗粒抑制剂
  • 批准号:
    10697442
  • 财政年份:
    2023
  • 资助金额:
    $ 5.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了